Validation of a screening program for undiagnosed myasthenia gravis using social media and self-assessment
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
ZS Associates · NCT06866483
This study is testing a self-assessment tool shared on social media to help people with possible myasthenia gravis symptoms find out if they should see a doctor for further evaluation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | ZS Associates (industry) |
| Locations | 1 site (Evanston, Illinois) |
| Trial ID | NCT06866483 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate a self-assessment tool designed to encourage individuals with undiagnosed neuromuscular symptoms to seek medical evaluation for suspected myasthenia gravis (MG). Participants will be recruited through a social media campaign and will complete a series of assessments, including the Impact of Daily Living (IDL) Survey and MG Physical Tests, to evaluate their symptoms. A neurologist will review the results to determine if further evaluation is necessary. The study expands on a pilot study that successfully diagnosed MG in previously undiagnosed individuals.
Who should consider this trial
Good fit: Ideal candidates are adults in the U.S. with undiagnosed neuromuscular symptoms who are fluent in English.
Not a fit: Patients already diagnosed with myasthenia gravis or other specified neurological conditions will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and treatment for patients with myasthenia gravis.
How similar studies have performed: Previous studies have shown success in using social media for recruitment and diagnosis of myasthenia gravis, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Reside within the 50 states of the United States at the time of enrollment * Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state * Active email account * Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form Exclusion Criteria: * Live in an overseas territory of the United States * Inability or unwillingness to provide written informed consent * Diagnosed myasthenia gravis, including sero-negative MG\* * Diagnosed multiple sclerosis * Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke
Where this trial is running
Evanston, Illinois
- ZS Associates — Evanston, Illinois, United States (RECRUITING)
Study contacts
- Study coordinator: Ananda Vishnu Pandurangadu, MD
- Email: support@unearthrootcause.com
- Phone: 1-847-448-1001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Myasthenia Gravis, Neuromuscular Disease, Neuromuscular Manifestations, social media, myasthenia gravis